Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectranetics' lead locking device is CE-marked and approved in Canada:

This article was originally published in Clinica

Executive Summary

Spectranetics has CE-marked its lead locking device (LLD) which has also been approved for marketing in Canada. The disposable, single-use product is designed to act as a stable traction platform during the removal of leads from cardiac pacemakers and implantable cardioverter defibrillators. The LLD is used in conjunction with laser-assisted lead removal products and is available in three sizes. According to the Colorado Springs, Colorado-based company, approximately 5%-10% of the 500,000 pacemaker and defibrillator leads implanted each year need to be extracted due to fracture or abandonment.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel